Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins

Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins

Bicalutamide (BCL) is a nonsteroidal antiandrogen drug that represents an alternative to castration in the treatment of prostate cancer, due to its relatively long half-life and tolerable side effects. However, it possesses a very low water solubility that can affect its oral bioavailability. In thi...

Full description

Bibliographic Details
Main Authors:	Federica De Gaetano, Maria Chiara Cristiano, Donatella Paolino, Consuelo Celesti, Daniela Iannazzo, Venerando Pistarà, Nunzio Iraci, Cinzia Anna Ventura
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Biomolecules
Subjects:	bicalutamide cyclodextrins molecular modeling in vitro biological studies DU-145 and PC3 cell lines
Online Access:	https://www.mdpi.com/2218-273X/12/11/1716

Similar Items

Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer
by: Sahar B. Kandil, et al.
Published: (2020-12-01)

Impact of bicalutamide, an anti-androgen on rat testis
by: Azheen Subhi Abdulrahman, et al.
Published: (2019-04-01)

Physicochemical Profile of Antiandrogen Drug Bicalutamide: Solubility, Distribution, Permeability
by: Tatyana V. Volkova, et al.
Published: (2022-03-01)

Computational Analysis of Interactions between Androgen Receptor and Bicalutamide
by: Noushin Hadian, et al.
Published: (2017-03-01)

Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer
by: Hiroshi Hongo, et al.
Published: (2014-09-01)

Mechanism of Bicalutamide to Breast Cancer Cell Lines MDA-MB-453 and Inhibitory Effects of Its Combination with Everolimus
by: ZHANG Yuqin, et al.
Published: (2021-03-01)

Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery
by: Federica De Gaetano, et al.
Published: (2021-08-01)

HPLC Analysis of Phytosterols in Prunus spinosa L. Extracts and Their Antiproliferative Activity on Prostate Cancer Cell Lines
by: Alema Dedić, et al.
Published: (2023-05-01)

Molecular Disorder of Bicalutamide—Amorphous Solid Dispersions Obtained by Solvent Methods
by: Joanna Szafraniec, et al.
Published: (2018-10-01)

The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer
by: Lei Tian, et al.
Published: (2022-11-01)

Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog–Thalidomide PROTACs
by: Ga Yeong Kim, et al.
Published: (2021-04-01)

Compression-Induced Phase Transitions of Bicalutamide
by: Joanna Szafraniec-Szczęsny, et al.
Published: (2020-05-01)

Is Irisin an Anticarcinogenic Peptide?
by: Suat Tekin, et al.
Published: (2015-06-01)

ELL2 Is Required for the Growth and Survival of AR-Negative Prostate Cancer Cells
by: Wang Z, et al.
Published: (2020-06-01)

Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer
by: Yuezheng Li, et al.
Published: (2023-04-01)

Amphiphilic Cyclodextrin Nanoparticles as Delivery System for Idebenone: A Preformulation Study
by: Federica De Gaetano, et al.
Published: (2023-03-01)

Multi-Matrix Approach for the Analysis of Bicalutamide Residues in Oncology Centers by HPLC–FLD
by: M. Francisca Portilha-Cunha, et al.
Published: (2021-09-01)

Development of machine learning classifiers to predict compound activity on prostate cancer cell lines
by: Davide Bonanni, et al.
Published: (2022-11-01)

Identification of PI3K Isoforms in Human Prostate Cancer Cell Lines (PC3, DU145) and Human Bladder Carcinoma Cell line (5637)
by: Hajar Aryan, et al.
Published: (2015-07-01)

The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer
by: Li Q, et al.
Published: (2019-12-01)

Therapeutic benefits of maximum androgen blockade and tolerability of bicalutamide in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2004-01-01)

Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer
by: Huina Wu, et al.
Published: (2024-01-01)

Bicalutamide-Associated Acute Liver Injury and Migratory Arthralgia: A Rare but Clinically Important Adverse Effect
by: Helga M. Gretarsdottir, et al.
Published: (2018-06-01)

Rutin/Sulfobutylether-β-Cyclodextrin as a Promising Therapeutic Formulation for Ocular Infection
by: Federica De Gaetano, et al.
Published: (2024-02-01)

Characterization and In Vivo Antiangiogenic Activity Evaluation of Morin-Based Cyclodextrin Inclusion Complexes
by: Federica De Gaetano, et al.
Published: (2023-08-01)

Exploring substituted 3,4-dihydropyrimidinone and thione derivatives as anti-prostate cancer agents: Computational screening, synthesis, characterization, and in vitro efficacy assessment
by: M.K.M. Abdul Lathiff, et al.
Published: (2024-01-01)

Cytotoxic effects of rhododendron ponticum l. extract on prostate carcinoma and adenocarcinoma cell line (du145, pc3)
by: Emine Kübra BİLİR, et al.
Published: (2018-03-01)

Another Move towards Bicalutamide Dissolution and Permeability Improvement with Acetylated β-Cyclodextrin Solid Dispersion
by: Tatyana V. Volkova, et al.
Published: (2022-07-01)

Lithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells
by: Ahmed A. Gafar, et al.
Published: (2016-11-01)

Refinement of an Established Procedure and Its Application for Identification of Hypoxia in Prostate Cancer Xenografts
by: Pernille B. Elming, et al.
Published: (2021-05-01)

CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling
by: Chih-Jen Lai, et al.
Published: (2019-03-01)

Anticancer activity of midostaurin in hormone refractory human prostate cancer DU145 cells
by: Jin-Jun Sun, et al.
Published: (2016-03-01)

Bicalutamide Elicits Renal Damage by Causing Mitochondrial Dysfunction <i>via</i> ROS Damage and Upregulation of HIF-1
by: Kuan-Chou Chen, et al.
Published: (2020-05-01)

Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone
by: Federica De Gaetano, et al.
Published: (2022-09-01)

The Use of High-Intensity Focused Ultrasound (HIFU) Plus 150mg Bicalutamide as First Line Salvage Therapy for Local Recurrent Prostate Cancer
by: Jian-zhou Cao, et al.
Published: (2021-11-01)

How Does the CO<sub>2</sub> in Supercritical State Affect the Properties of Drug-Polymer Systems, Dissolution Performance and Characteristics of Tablets Containing Bicalutamide?
by: Agata Antosik-Rogóż, et al.
Published: (2020-06-01)

Bicalutamide Exhibits Potential to Damage Kidney via Destroying Complex I and Affecting Mitochondrial Dynamics
by: Kuan-Chou Chen, et al.
Published: (2021-12-01)

Anticancer Activity of Water and Methanol Extracts of Hypericum scabrum L. on Different Cancer Cell Lines
by: Gulsen GUCLU, et al.
Published: (2019-12-01)

Calcium signaling in prostate cancer cells of increasing malignancy
by: Marchetti Carla
Published: (2022-03-01)

Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-<i>β</i>-Cyclodextrin Inclusion Complex <xref rid="fn1-biomolecules-570665" ref-type="fn">†</xref>
by: Valentina Venuti, et al.
Published: (2019-09-01)